CYBERDYNE Inc. (CYBQF)
OTCMKTS
· Delayed Price · Currency is USD
1.300
0.00 (0.00%)
At close: Mar 20, 2025
CYBERDYNE Revenue
CYBERDYNE had revenue of 1.03B JPY in the quarter ending December 31, 2024, a decrease of -7.98%. This brings the company's revenue in the last twelve months to 4.30B, up 4.11% year-over-year. In the fiscal year ending March 31, 2024, CYBERDYNE had annual revenue of 4.35B with 32.38% growth.
Revenue (ttm)
4.30B JPY
Revenue Growth
+4.11%
P/S Ratio
9.32
Revenue / Employee
18.96M JPY
Employees
227
Market Cap
255.19M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 4.35B | 1.07B | 32.38% |
Mar 31, 2023 | 3.29B | 1.14B | 52.98% |
Mar 31, 2022 | 2.15B | 275.00M | 14.67% |
Mar 31, 2021 | 1.88B | 83.00M | 4.63% |
Mar 31, 2020 | 1.79B | 83.00M | 4.86% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |